Edition:
India

United Laboratories International Holdings Ltd (3933.HK)

3933.HK on Hong Kong Stock

4.70HKD
18 Apr 2019
Change (% chg)

HK$-0.15 (-3.09%)
Prev Close
HK$4.85
Open
HK$4.83
Day's High
HK$4.86
Day's Low
HK$4.68
Volume
6,818,500
Avg. Vol
4,294,493
52-wk High
HK$9.75
52-wk Low
HK$3.93

Latest Key Developments (Source: Significant Developments)

United Laboratories International Holdings Posts FY Profit Attributable RMB81.8 MLN
Thursday, 29 Mar 2018 

March 29 (Reuters) - United Laboratories International Holdings Ltd <3933.HK>::FY PROFIT ATTRIBUTABLE RMB81.8 MILLION VERSUS LOSS RMB272.4 MLN‍​.FY ‍REVENUE RMB 6.83 BILLION VERSUS RMB 6.08 BILLION​.‍BOARD PROPOSES A FINAL DIVIDEND OF RMB5 CENTS PER SHARE​.  Full Article

United Laboratories International Expects ‍To Record FY Profit Of About RMB80 Mln
Thursday, 22 Mar 2018 

March 22 (Reuters) - United Laboratories International Holdings Ltd <3933.HK>::EXPECTS ‍TO RECORD A PROFIT OF ABOUT RMB80 MILLION​ FOR FY.EXPECTED FY RESULT DUE TO ‍INCREASE IN SALES PRICES OF INTERMEDIATE AND BULK MEDICINE PRODUCTS​.  Full Article

United Laboratories International ‍signs facility agreement with China Development Bank Hong Kong
Tuesday, 10 Oct 2017 

Oct 10 (Reuters) - United Laboratories International Holdings Ltd <3933.HK>:‍Entered facility agreement with China Development Bank Hong Kong for HK$300 million and HK$200 million term loans​.  Full Article

United Laboratories posts HY profit for period attributable RMB 109.1 mln vs loss of RMB13.5 mln
Thursday, 24 Aug 2017 

Aug 24 (Reuters) - United Laboratories International Holdings Ltd <3933.HK>:HY profit for period attributable to shareholders is approximately RMB109.1 million (first half of 2016: loss of RMB13.5 million).HY revenue RMB 3.3 million, up 12.7 percent.  Full Article

United Laboratories International expects to record profit of about RMB100 million for HY
Thursday, 17 Aug 2017 

Aug 17 (Reuters) - United Laboratories International Holdings Ltd <3933.HK>::Group's unaudited interim results for HY is expected to record a profit of about RMB100 million.Expected result due to increase in sales of intermediate and bulk medicine products.  Full Article